Oncimmune Holdings (GB:ONC) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Oncimmune Holdings has secured three new contracts valued at £0.34 million, building on its recent commercial success of £2.14 million in contracts over the past three months. The deals with top global pharmaceutical companies highlight Oncimmune’s growing reputation and ability to secure repeat business. As the company progresses, it remains on track to meet its FY2025 revenue targets, showcasing its potential for profitability.
For further insights into GB:ONC stock, check out TipRanks’ Stock Analysis page.